טוען...
Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasis
BACKGROUND: Evidence of the comparative effectiveness of biological therapies for psoriasis on health‐related quality of life (HRQoL) in routine clinical practice is limited. OBJECTIVES: To examine the comparative effectiveness of adalimumab, etanercept and ustekinumab on HRQoL in patients with psor...
שמור ב:
| הוצא לאור ב: | Br J Dermatol |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6487951/ https://ncbi.nlm.nih.gov/pubmed/28369707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjd.15531 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|